The impact of completeness of last transurethral resection of bladder tumors on the outcomes of radical cystectomy-Reference-Cited by-同舟云学术

The impact of completeness of last transurethral resection of bladder tumors on the outcomes of radical cystectomy

Published:2019-03-25 Issue:12 Volume:37 Page:2707-2714
ISSN:0724-4983
Container-title:World Journal of Urology
language:en
Short-container-title:World J Urol

Author:

Zamboni Stefania,Moschini Marco,Gallina Andrea,Colombo Renzo,Montorsi Francesco,Briganti Alberto,Salonia Andrea,Antonelli Alessandro,Simeone Claudio,Belotti Sandra,Cristinelli Luca,Mattei Agostino,Baumeister Philipp

Publisher

Springer Science and Business Media LLC

Subject

Urology

Link

http://link.springer.com/content/pdf/10.1007/s00345-019-02734-6.pdf

Reference28 articles.

1. Siegel RL, Miller KD, Jemal A (2018) Cancer statistics, 2018. CA Cancer J Clin 68:7–30. https://doi.org/10.3322/caac.21442

2. Babjuk M, Böhle A, Burger M, Capoun O, Cohen D, Compérat EM et al (2017) EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016. Eur Urol 71:447–461. https://doi.org/10.1016/j.eururo.2016.05.041

3. Mariappan P, Finney SM, Head E, Somani BK, Zachou A, Smith G et al (2012) Good quality white-light transurethral resection of bladder tumours (GQ-WLTURBT) with experienced surgeons performing complete resections and obtaining detrusor muscle reduces early recurrence in new non-muscle-invasive bladder cancer: validation across time and place and recommendation for benchmarking. BJU Int 109:1666–1673. https://doi.org/10.1111/j.1464-410X.2011.10571.x

4. Divrik RT, Sahin AF, Yildirim U, Altok M, Zorlu F (2010) Impact of routine second transurethral resection on the long-term outcome of patients with newly diagnosed pT1 urothelial carcinoma with respect to recurrence, progression rate, and disease-specific survival: a prospective randomised clinical trial. Eur Urol 58:185–190. https://doi.org/10.1016/j.eururo.2010.03.007

5. Chang SS, Bochner BH, Chou R, Dreicer R, Kamat AM, Lerner SP et al (2017) Treatment of non-metastatic muscle-invasive bladder cancer: AUA/ASCO/ASTRO/SUO guideline. J Urol 198:552–559. https://doi.org/10.1016/j.juro.2017.04.086

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanoreactor based on single-atom nanoenzymes promotes ferroptosis for cancer immunotherapy;Biomaterials Advances;2024-02

2. Dose-Escalated Radiation Therapy as Primary Treatment for Residual Bladder Cancer After Transurethral Resection;Advances in Radiation Oncology;2024-01

3. Repeat Transurethral Resection of Muscle-invasive Bladder Cancer Prior to Radical Cystectomy Is Prognostic but Not Therapeutic. Reply.;Journal of Urology;2023-08

4. Editorial Comment;Journal of Urology;2023-05

5. Impact of Maximal Transurethral Resection on Pathological Outcomes at Cystectomy in a Large, Multi-institutional Cohort;Journal of Urology;2023-05